NewsBenzingaHC 웨인라이트, 오릭 파마슈티컬스 투자의견 ‘매수’ 유지, 목표주가 20달러로 하향 조정 HC 웨인라이트, 오릭 파마슈티컬스 투자의견 ‘매수’ 유지, 목표주가 20달러로 하향 조정 Benzinga 2026.11.19 11:27 (GMT+0) Open on Benzinga Other news HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Lowers Price Target to $20 Kash Patel Skips House Hearing After Attending Trump’s Mar-a-Lago Gala Offering $50,000 Access to Top Officials, Draws Bipartisan Criticism: Report HC Wainwright & Co. Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target Needham Reiterates Buy on Palo Alto Networks, Maintains $425 Price Target BTIG Maintains Buy on Palo Alto Networks, Raises Price Target to $442
Kash Patel Skips House Hearing After Attending Trump’s Mar-a-Lago Gala Offering $50,000 Access to Top Officials, Draws Bipartisan Criticism: Report